XML 44 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements - (Tables)
6 Months Ended
Jun. 28, 2020
Fair Value Disclosures [Abstract]  
Schedule of Financial Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of June 28, 2020, and December 29, 2019:
(In thousands)
 
June 28, 2020
 
December 29, 2019
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short-term AFS securities (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt securities
 
$
106,271

 
$

 
$
106,271

 
$

 
$
99,126

 
$

 
$
99,126

 
$

U.S. Treasury securities
 
79,004

 

 
79,004

 

 
43,095

 

 
43,095

 

U.S. governmental agency securities
 
36,144

 

 
36,144

 

 
37,502

 

 
37,502

 

Commercial paper
 
15,981

 

 
15,981

 

 
12,561

 

 
12,561

 

Certificates of deposit
 
3,000

 

 
3,000

 

 
9,501

 

 
9,501

 

Total short-term AFS securities
 
$
240,400

 
$

 
$
240,400

 
$

 
$
201,785

 
$

 
$
201,785

 
$

Long-term AFS securities (1)
 

 

 

 

 

 

 

 

Corporate debt securities
 
$
116,341

 
$

 
$
116,341

 
$

 
$
103,737

 
$

 
$
103,737

 
$

U.S. Treasury securities
 
95,394

 

 
95,394

 

 
101,438

 

 
101,438

 

U.S. governmental agency securities
 
55,211

 

 
55,211

 

 
46,521

 

 
46,521

 

Total long-term AFS securities
 
$
266,946

 
$

 
$
266,946

 
$

 
$
251,696

 
$

 
$
251,696

 
$

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deferred compensation (2)(3)
 
$
18,871

 
$
18,871

 
$

 
$

 
$
23,702

 
$
23,702

 
$

 
$


(1) We classified these investments as Level 2 since the fair value is based on market observable inputs for investments with similar terms and maturities.
(2) The deferred compensation liability, included in Other liabilities—other in our Condensed Consolidated Balance Sheets, consists of deferrals under The New York Times Company Deferred Executive Compensation Plan (the “DEC”), which previously enabled certain eligible executives to elect to defer a portion of their compensation on a pre-tax basis. The deferred amounts are invested at the executives’ option in various mutual funds. The fair value of deferred compensation is based on the mutual fund investments elected by the executives and on quoted prices in active markets for identical assets. Participation in the DEC was frozen effective December 31, 2015.
(3) The Company invests the assets associated with the deferred compensation liability in life insurance products. Our investments in life insurance products are included in Miscellaneous assets in our Condensed Consolidated Balance Sheets, and were $45.1 million as of June 28, 2020, and $46.0 million as of December 29, 2019. The fair value of these assets is measured using the net asset value per share (or its equivalent) and has not been classified in the fair value hierarchy.